Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stopping maintenance immunosuppression after 2 years in proliferative lupus nephritis
2010-022859-30Phase 3Active
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mycophenolate mofetil and azathioprine in lupus nephritis (LN) and systemic lupus erythematosus (SLE) (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Renal histologic relapse definition. Started Sep 2010; status: active.
02
Drugs
mycophenolate mofetilazathioprine
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2010-022859-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022859-30.